Gene involved in immortalization of human cancer cell and use thereof
AssigneeKabushiki Kaisha Yakult Honsha
InventorsMasahiko Nishiyama, Keiko Hiyama, Keiji Tanimoto, Norio Masuko
Life of this patent
Estimating the term…
Loading patent…
AssigneeKabushiki Kaisha Yakult Honsha
InventorsMasahiko Nishiyama, Keiko Hiyama, Keiji Tanimoto, Norio Masuko
Estimating the term…
The present invention provides a gene related to cancer cell immortalization (an immortalization determining gene) and a process that is useful for selective cancer treatment targeting a cancer cell having the gene. The present invention determines an immortalized cancer cell using a polynucleotide having a base sequence of at least 15 bases that specifically hybridizes with a continuous base sequence of at least 15 bases within any one of abase sequences represented by SEQ ID Nos. 1 to 13. In the foregoing process, the polynucleotide is used as a primer or probe for detecting an immortalization determining gene that exhibits high expression specifically in an immortalized cancer cell.
A marker gene for determining cancer cell immortalization, the marker gene comprising a polynucleotide having a base sequence of at least 15 bases that specifically hybridizes with a continuous base sequence of at least 15 bases within any one of base sequences represented by SEQ ID Nos.1 to 13.
An antibody for recognizing a polypeptide having any one of amino acid sequences represented by SEQ ID Nos.14 to 26.
A method for screening a substance for suppressing proliferation of immortalized cancer cells, comprising the steps of:
A method for screening a substance for suppressing proliferation of immortalized cancer cells, comprising the steps of:
An immortalized cancer cell growth inhibitor containing, as an active ingredient, a polynucleotide having a base sequence of at least 15 bases that specifically hybridizes with a continuous base sequence of at least 15 bases within any one of base sequences represented by SEQ ID Nos. 1 to 13.
Use of a polynucleotide having a base sequence of at least 15 bases that specifically hybridizes with a continuous base sequence of at least 15 bases within any one of base sequences represented by SEQ ID Nos. 1 to 13, for producing an immortalized cancer cell growth inhibitor.
Dependencies are inferred from the claim text.